Alpelisib
Alpelisib is an orally bioavailable PI3Kα inhibitor (IC50: 5 nM in a cell-free assay) with potential antineoplastic activity and minimal effect on PI3Kβ/γ/δ.
| Catalog Number | T1921 |
| Alternative Name(s) | BYL-719 |
| Research Area | PI3K/Akt/mTOR signaling |
| Molecular Formula | C19H22F3N5O2S |
| CAS# | 1217486-61-7 |
| Purity | 99.07% |
| SMILES | Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F |
| Size | 500 mg |
| Supplier Page | https://www.targetmol.com/compound/Alpelisib |
| Additional Information | https://www.targetmol.com/datasheet/T1921 |